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Decades of educating the public about the warning signs of
a heart attack has had the beneficial effect of prompting
individuals with bona fide myocardial infarction to quickly
seek medical attention, but at the same time induces many
more individuals experiencing benign chest pain to present
to emergency departments (ED) for evaluation. Even
though most patients with acute chest pain are not ulti-
mately diagnosed with acute coronary syndrome, establish-
ing this with certainty consumes time, labor, already over-
crowded ED and hospital space, and money. Despite efforts
to improve the triage of this presentation, up to 5% of acute
coronary syndromes are still missed (1,2), and these undi-
agnosed patients face a higher adverse event rate than those
who are correctly diagnosed (3), such that even low miss
rates are essentially intolerable. Hence, ED physicians face
the difficult challenge of trying to be nearly perfect predic-
tors of their patients’ outcomes at the same time that they
must lower costs and shorten patient turnaround time, and
they must do this in today’s highly litigious environment (4).
All together, these factors understandably incline many ED
physicians to use cardiac imaging as a way to boost their
chances of successfully managing this common and chal-
lenging entity.
See page 880
Soon after its emergence, it was realized that coronary
computed tomographic angiography (CTA) possessed an
impressive ability to accurately exclude coronary artery
disease and coronary stenosis. Given its strong negative
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been interest in using coronary CTA to aid the evaluation of
chest pain in the ED. Recently, the small number of
randomized trials evaluating this question has grown, and
the study by Hulten et al. (5), in this issue of the Journal, is
the first meta-analysis to examine randomized controlled
trials of ED triage of acute chest pain using coronary CTA,
comparing this relatively new approach to more traditional
usual care (UC) methods.
Four trials were adequate for inclusion, totaling 3,266
patients. Generally speaking, there were similar inclusion/
exclusion criteria across the studies, and patients had similar
coronary heart disease risk factors in the CTA and compar-
ison groups. There were no deaths in any of the studies and
a minimal number of myocardial infarctions. This is perhaps
not surprising given the low-risk population selected, but a
testament to the safety of the CTA approach nonetheless,
especially given the rapid turnaround times for the CT
patients: in most cases, a “negative” coronary CTA meant
immediate discharge home. Invasive coronary angiography
(ICA) occurred in 7.6% of the CT subjects (8.4% when the
data are pooled and weighted) and 6.3% of the UC subjects
(same when pooled and weighted). Hence, the absolute
difference in the pooled weighted incidences was about 2%,
with an odds ratio of 1.36, though with a lower confidence
limit just above the threshold of statistical significance at
1.03. Similarly, revascularization occurred in 4.1% of the
CT subjects (4.6% when pooled and weighted) and 2.6% of
the UC group, which perhaps is not surprising given that
there was a slightly higher rate of ICA in the CT group.
This meta-analysis did not attempt to compare length of
stay or cost because of the methodological heterogeneity of
the studies, but the investigators point out that all of the
source studies reported significant reductions in length of
stay for the CT group. Coronary CTA is a quick procedure;
most patients, having already established intravenous access
and received beta-blockers in the ED, are in and out of the
scanner room in 20 min. At our center, we usually have the
reading done before the patient makes it back to the ED.
Our ED physicians find this time-saving approach ex-
tremely helpful as they battle the time constraints so
common to any busy ED. Hulten et al. also point out that
in addition to saving time, all the source studies that
evaluated ED cost reported significant cost savings. These
data have supported the hypothesis that a CT strategy in the
evaluation of ED chest pain saves time and money, and its
use in this scenario is supported by recent guidelines (6,7).
Hulten et al. (5) conclude from their meta-analysis that
the use of coronary CTA to triage ED chest pain is safe,
consistently reduces length of stay, and reduces ED cost, but
compared with traditional methods, is associated with
slightly higher rates of ICA and revascularization. These
differences were not statistically significant in any of the
source studies, but they do reach the statistical threshold
with the increased number of subjects afforded by the
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this correlation does not prove that coronary CTA “leads” to
ICA or revascularization, it is an intriguing finding worth
examining more closely.
It is important to point out that there were some
significant differences in methodology among these 4 stud-
ies. The studies by Goldstein et al. (8) and the CT-STAT
(Coronary Computed Tomographic Angiography for Sys-
tematic Triage of Acute Chest Pain Patients to Treatment)
Investigators (9) were comparisons of CT not to clinical
triage but to another imaging modality, namely single-
photon emission CT (SPECT); no patients were to be
discharged without 1 of these 2 imaging tests (8,9). Perhaps
this is relevant: in CT-STAT, the 6-month cumulative ICA
rates in the 2 groups were nearly the same: 8% in the CTA
group versus 7.4% in the single-photon emission CT group
(p  0.78). This is different from ROMICAT II (Rule Out
Myocardial Ischemia/Infarction Using Computer Assisted
Tomography) and ACRIN PA 4005 (CT Angiography for
Safe Discharge of Patients With Possible Acute Coronary
Syndromes) trials in which patients could potentially be
discharged without any testing. Hence, they were not
susceptible to the false-positive tests that plague some
noninvasive modalities. Goldstein et al. (8) and CT-STAT
(9) were also different in that the protocol required recom-
mending additional testing after CT given certain criteria:
SPECT for any stenosis 25%, or even just a calcium score
100, and ICA for any stenosis 70%. This very conser-
vative approach may well have contributed to a higher
catheterization rate. Indeed, when those 2 studies are
removed, the lower confidence limit of the odds ratio for
ICA in the CT group nudges even closer to the nonsignif-
icant level at 1.004. Hence, the association demonstrated
between CT and ICA is not exactly strong.
That aside, Hulten et al. (5) point out that ICA and
revascularization contribute to the cost of care. This, gen-
erally speaking, is true, but raises 2 other issues worth
pointing out. The first is particular to the studies of acute
chest pain triage, which is that most patients (90%) in
these studies did not undergo either ICA or revasculariza-
tion. In the evaluation of acute chest pain, the more
frequent source of cost is the diagnostic workup in the ED.
In this regard, the use of coronary CTA, compared to the
UC strategy, has consistently been shown in multiple
randomized trials to reduce ED costs and to offset the cost
of additional ICA or revascularization.
The second issue concerns those catheterizations and
revascularizations and is a more general point pertaining to
healthcare costs. As we try to reduce healthcare spending,
let us not confuse quantity with quality. Whereas some
advocate broadly curtailing the use of all tests and proce-
dures in a nearly indiscriminate fashion, in fact the use of
these tools, and the costs associated with their use, are either
justified or unjustified depending on the circumstances of
the particular patients and clinical scenarios in which we use
them. We should not seek to reduce the usage of resourcesjust for its own sake; rather, we should look for ways to
reduce unnecessary usage. For this reason, comparing the
incidence of downstream resource utilization after coronary
CTA, though an interesting start, only touches the surface
of the issue. The more critical issue is whether these
procedures are being used appropriately. However, the
question of appropriateness was not examined by this
meta-analysis or any of the source studies and for a variety
of good reasons. There are numerous and varied factors that
play into the decision to perform these procedures; clinical
outcome studies in this patient population would require
large numbers of subjects because event rates are low; and
diagnostic tests themselves do not exert any treatment effect,
so to truly test the effect of a diagnostic strategy on clinical
outcomes requires that treatments and therapies be strictly
dictated, per protocol, by the results of the test.
Yet the data in hand may provide a little insight. In all of
the source studies, individually and as a whole, catheteriza-
tions prompted by coronary CTA were more often followed
by revascularization than were catheterizations prompted by
other approaches. Some would say that this indicates that
coronary CTA drives revascularization, but this is not the
case. The decision to revascularize is generally made based
on the findings of the invasive angiogram, not the nonin-
vasive test that preceded it. Instead, it would appear that
when the coronary CTA strategy does prompt an invasive
angiogram, those angiograms provide a higher diagnostic
yield. For example, in ACRIN PA 4005, there were
equivalent rates of cardiac catheterization in the CTA and
control arms (4%), but in the CTA group, the prevalence of
significant disease on the invasive angiogram was 76%
versus 44% in the traditional care group (10). Across the 4
studies included in this meta-analysis, the diagnostic yield of
catheterizations prompted by coronary CTA was higher
than for those prompted by usual care (54% vs. 41%), even
including the requirements to test and catheterize in-
cluded in Goldstein et al. (8) and CT-STAT (9). These
data suggest that the CTA strategy may help select
patients for ICA and thereby reduce the number of
unnecessary catheterizations.
If the CTA strategy reduces the number of unnecessary
catheterizations, then why were there more revasculariza-
tions in the CTA group? Perhaps the real question is why
there were fewer revascularizations in the UC group. All the
patients in the CTA group essentially got an angiogram,
and coronary CTA is exquisitely sensitive for the detection
of coronary disease. On the other hand, 94% of the patients
in the UC group never had their coronary arteries “looked
at.” That is not necessarily a bad thing. But, are some
patients in the UC group with obstructive coronary disease
being missed and sent home without that diagnosis? Per-
haps. Do they suffer a higher morbidity or mortality than
those detected and revascularized? Presumably that depends
on the extent and severity of their disease, but we will not
know until we have much larger studies to find out. In the
meantime, the time pressures, budget constraints, and legal
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very real forces will continue to put pressure on front-line
physicians and strain our healthcare resources. In the end, it
may be our healthcare delivery systems that benefit most
from a fast, accurate, cost-saving test.
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